Everest Ventures

Legendsemi is a company dedicated to the development and design of high-performance analog and mixed-signal chips. It specializes in creating mid-to-high-end digital-analog hybrid products, focusing on the research and development of semiconductor solutions that primarily involve high-precision signal chains and signal chain microcontrollers or system-on-chips. Through its innovative approach, Legendsemi aims to deliver advanced technology that meets the demands of modern electronic applications.

Evrynet is a developer of an advanced financial services platform that facilitates the creation of centralized and decentralized finance (CeDeFi) applications. The company's infrastructure utilizes blockchain technology to offer fundamental financial templates, serving as a foundation for more complex financial functions and decentralized finance applications. Evrynet's platform incorporates smart contracts, allowing both individuals and enterprises to easily develop financial applications that are interoperable with various leading blockchains. This capability enables a seamless integration of diverse financial services, catering to the needs of developers and businesses in the evolving landscape of finance.

XCarnival operates as a crypto influencer, focusing on the development of a synthetic asset platform that provides exposure to various cryptocurrencies. The company specializes in non-standard asset leasing, pawning, and lending, offering investors the opportunity to engage with NFT assets without direct involvement in their underlying assets. With features that include synthetic markets for asset swapping and services for optimizing and liquidating assets, XCarnival aims to enhance the investment experience in the rapidly evolving digital asset space.

7SIGNAL is an enterprise wireless experience monitoring company that offers a cloud-based platform designed to continuously assess wireless networks and identify performance issues affecting application functionality. By employing an "outside-in" monitoring approach, the platform provides visibility at the edge of both enterprise and home Wi-Fi networks, where user experience is critical. This capability enhances employee productivity, operational efficiency, and network return on investment. Targeted towards innovative organizations, educational institutions, healthcare systems, and government entities, 7SIGNAL's system is utilized by Fortune 500 companies, hospitals, and large venues worldwide. It simplifies the management of business-critical wireless LANs, reduces total ownership costs, and facilitates quicker problem resolution, particularly in remote environments, without the need to add extra wireless access points.

Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.